MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways
Author:
Affiliation:
1. Department of Ophthalmology, The First People's Hospital of Shangqiu, Shangqiu, Henan 476100, P.R. China
2. Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma;Current Issues in Molecular Biology;2024-05-27
2. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma;Canadian Journal of Ophthalmology;2024-02
3. Network pharmacology-based approach to investigate the molecular targets of essential oil obtained from lavender for treating breast cancer;Heliyon;2023-11
4. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses;Pathology - Research and Practice;2023-07
5. The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target;Medical Oncology;2022-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3